感染性内心炎手术风险评分的比较:一个元分析
Ankit Agrawal1, Aro Daniela Arockiam1, Joseph El Dahdah1
1Section of Cardiovascular Imaging, Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.
Angiology
|January 17, 2025
概括
预测感染性内心炎 (IE) 手术后的死亡率至关重要. 欧洲Score II和特定的IE分数显示中度准确性,ANCLA在IE特定模型中表现最好.
科学领域:
- 心脏外科手术 心脏外科手术
- 传染性内心炎感染性内心炎
- 预测的准确性 预测的准确性
背景情况:
- 现有的心脏手术死亡率评分系统在传染性内心炎 (IE) 中具有不确定的效用.
- 在IE中准确预测手术死亡率对于临床决策至关重要.
研究的目的:
- 为了比较各种风险评分的预后准确性,预测IE手术患者的手术后死亡率.
- 评估传统和IE特定风险评分的表现.
主要方法:
- 对Ovid Medline,Embase和Cochrane控制试验中心注册的系统审查.
- 15项研究的元分析包括使用Open-Meta[Analyst]的研究和使用Review Manager 5.4.4的校准分析.
- 在IE手术中对手术死亡率歧视的12个风险评分的分析.
主要成果:
- 操作死亡率歧视曲线下的面积 (AUC) 在12个风险分数中从0.64到0.83不等.
- 在IE特定得分中,ANCLA显示了最高的AUC (0.838),其次是AEPEI (0.764),RISK-E (0.752) 和APORTEI (0.750).
- 与EuroSCORE I相比,EuroSCORE II实现了0.750的AUC,但低估了死亡率.
结论:
- 欧斯科尔II和几个IE特异性风险评分在预测IE手术后的死亡率方面表现出中度的歧视 (AUC>0.75).
- 作为IE特定风险评分,ANCLA显示出有前途的表现.
- 这些分数在不同的IE群体中需要进一步验证.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
115
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
115
01:20Comparing the Survival Analysis of Two or More Groups
141
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
141